Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Predictive Oncology ROE 2010-2025 | POAI

Current and historical return on equity (ROE) values for Predictive Oncology (POAI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Predictive Oncology ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-06-30 $-0.01B $0.00B 0.00%
2025-03-31 $-0.01B $0.00B -666.67%
2024-12-31 $-0.01B $0.00B -480.00%
2024-09-30 $-0.01B $0.00B -288.89%
2024-06-30 $-0.01B $0.00B -185.71%
2024-03-31 $-0.01B $0.00B -143.59%
2023-12-31 $-0.01B $0.01B -96.30%
2023-09-30 $-0.02B $0.01B -105.88%
2023-06-30 $-0.02B $0.02B -88.37%
2023-03-31 $-0.03B $0.02B -95.24%
2022-12-31 $-0.03B $0.02B -81.30%
2022-09-30 $-0.03B $0.03B -70.92%
2022-06-30 $-0.03B $0.03B -65.41%
2022-03-31 $-0.02B $0.04B -42.70%
2021-12-31 $-0.02B $0.04B -45.20%
2021-09-30 $-0.02B $0.05B -65.71%
2021-06-30 $-0.03B $0.05B -96.15%
2021-03-31 $-0.03B $0.04B -165.08%
2020-12-31 $-0.03B $0.00B -291.89%
2020-09-30 $-0.03B $0.01B -266.67%
2020-06-30 $-0.03B $0.01B -200.00%
2020-03-31 $-0.02B $0.01B -137.50%
2019-12-31 $-0.02B $0.01B -148.15%
2019-09-30 $-0.01B $0.02B -83.72%
2019-06-30 $-0.01B $0.02B -128.00%
2019-03-31 $-0.01B $0.00B -733.33%
2018-12-31 $-0.01B $0.00B -363.64%
2018-09-30 $-0.01B $0.00B -228.57%
2018-06-30 $-0.01B $0.00B -184.62%
2018-03-31 $-0.01B $0.01B -215.38%
2017-12-31 $-0.01B $0.00B -200.00%
2017-09-30 $-0.01B $0.00B -240.00%
2017-06-30 $-0.01B $0.00B -300.00%
2017-03-31 $-0.01B $0.00B -400.00%
2016-12-31 $-0.01B $0.00B -560.00%
2016-09-30 $-0.01B $0.00B -400.00%
2016-06-30 $-0.01B $0.00B -228.57%
2016-03-31 $-0.01B $0.00B -342.86%
2015-12-31 $0.00B $0.00B 800.00%
2015-09-30 $0.00B $0.01B 133.33%
2015-06-30 $0.00B $-0.01B 72.73%
2015-03-31 $-0.01B $-0.01B 105.26%
2014-12-31 $-0.01B $-0.01B 186.67%
2014-09-30 $-0.01B $0.00B 233.33%
2014-06-30 $-0.01B $0.00B 444.44%
2014-03-31 $-0.01B $0.00B 400.00%
2013-12-31 $-0.01B $0.00B 360.00%
2013-09-30 $-0.01B $0.00B 360.00%
2013-06-30 $-0.01B $0.00B 290.91%
2013-03-31 $-0.01B $0.00B 360.00%
2012-12-31 $-0.01B $0.00B 320.00%
2012-09-30 $-0.01B $0.00B 360.00%
2012-06-30 $-0.01B $0.00B 280.00%
2012-03-31 $-0.01B $0.00B 200.00%
2011-12-31 $0.00B $0.00B 177.78%
2011-09-30 $0.00B $0.00B 50.00%
2011-06-30 $0.00B $0.00B 0.00%
2011-03-31 $0.00B $0.00B 0.00%
2010-12-31 $0.00B $0.00B 50.00%
2010-09-30 $0.00B $0.00B 50.00%
2010-06-30 $0.00B $0.00B 100.00%
2010-03-31 $0.00B $0.00B 200.00%
2009-12-31 $0.00B $0.00B 300.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.009B $0.002B
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $44.935B 57.17
Tempus AI (TEM) United States $12.393B 0.00
Doximity (DOCS) United States $11.901B 52.95
Hims & Hers Health (HIMS) United States $10.549B 87.28
IRhythm Technologies (IRTC) United States $5.208B 0.00
Hinge Health (HNGE) United States $4.462B 0.00
Privia Health (PRVA) United States $2.542B 188.27
Inspire Medical Systems (INSP) United States $2.501B 36.77
Phreesia (PHR) United States $1.667B 0.00
Enovis (ENOV) United States $1.647B 8.71
10x Genomics (TXG) United States $1.630B 0.00
Omnicell (OMCL) United States $1.446B 27.85
Schrodinger (SDGR) United States $1.427B 0.00
Azenta (AZTA) United States $1.402B 61.18
Clover Health Investments (CLOV) United States $1.317B 0.00
Claritev (CTEV) United States $1.117B 0.00
Evolent Health (EVH) United States $1.035B 0.00
Fulgent Genetics (FLGT) United States $0.665B 0.00
Zepp Health (ZEPP) Netherlands $0.509B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Standard BioTools (LAB) United States $0.463B 0.00
Talkspace (TALK) United States $0.424B 126.50
Carlsmed (CARL) $0.370B 0.00
Butterfly Network (BFLY) United States $0.355B 0.00
TruBridge (TBRG) United States $0.287B 50.40
Nyxoah SA (NYXH) Belgium $0.232B 0.00
Outset Medical (OM) United States $0.229B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.222B 0.00
Health Catalyst (HCAT) United States $0.206B 0.00
KORU Medical Systems (KRMD) United States $0.190B 0.00
CapsoVision (CV) United States $0.186B 0.00
MDxHealth SA (MDXH) Belgium $0.134B 0.00
American Well (AMWL) United States $0.117B 0.00
CareCloud (CCLD) United States $0.108B 4.92
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.093B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.069B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
111 (YI) China $0.057B 0.00
P3 Health Partners (PIII) United States $0.050B 0.00
HeartBeam (BEAT) United States $0.038B 0.00
Zhongchao (ZCMD) China $0.024B 0.00
Precipio (PRPO) United States $0.024B 0.00
Healthcare Triangle (HCTI) United States $0.019B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
MSP Recovery (MSPR) United States $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00